Publication:
Battling HIV/AIDS : A Decision Maker's Guide to the Procurement of Medicines and Related Supplies

Simple item page
dc.contributor.authorTayler, Yolanda
dc.contributor.editorTayler, Yolanda
dc.date.accessioned2013-08-08T18:37:33Z
dc.date.available2013-08-08T18:37:33Z
dc.date.issued2004
dc.description.abstractThis Guide sets out principles and advice for the procurement of HIV/AIDS medicines and related supplies for programs scaling up antiretroviral therapy (ART) and associated health services, such as basic and palliative care, disease prevention, treatment of opportunistic infections, and laboratory tests. ART includes the treatment of infected adults and children and the prevention of mother-to-child transmission. A wide range of other commodities-particularly condoms and support for basic living and care-are also essential to support the treatment and prevention of HIV. The primary audience for this guide is World Bank staff and those responsible for procuring HIV/AIDS medicines and related supplies in Bank-funded programs and projects-which could include either procurement agency staff or technical agency staff. Policymakers and Bank partners will also benefit from the information and advice in the guide.en
dc.identifierhttp://documents.worldbank.org/curated/en/2004/01/4987913/battling-hivaids-decision-makers-guide-procurement-medicines-related-supplies
dc.identifier.doi10.1596/0-8213-5848-0
dc.identifier.isbn0-8213-5848-0
dc.identifier.urihttps://hdl.handle.net/10986/14938
dc.languageEnglish
dc.language.isoen_US
dc.publisherWashington, DC
dc.rightsCC BY 3.0 IGO
dc.rights.holderWorld Bank
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/igo
dc.subjectACCESS TO TREATMENT
dc.subjectADHERENCE TO TREATMENT
dc.subjectADOLESCENTS
dc.subjectAIDS ORPHANS
dc.subjectAIDS PROGRAMS
dc.subjectAIDS TREATMENT
dc.subjectANTIRETROVIRAL DRUGS
dc.subjectARVS
dc.subjectAWARENESS CAMPAIGNS
dc.subjectBIDDING
dc.subjectBLOOD SAFETY
dc.subjectBREAST MILK
dc.subjectBREASTFEEDING
dc.subjectCENTRAL MEDICAL STORES
dc.subjectCLINICAL TRIALS
dc.subjectCOMMODITIES
dc.subjectCOMMUNITY EDUCATION
dc.subjectCONDOMS
dc.subjectCRITICAL APPRAISAL
dc.subjectDEVELOPED COUNTRIES
dc.subjectDEVELOPMENT GOALS
dc.subjectDISEASE PREVENTION
dc.subjectDRUG FORMULARY
dc.subjectDRUG PRICES
dc.subjectDRUG RESISTANCE
dc.subjectDRUG SELECTION
dc.subjectDRUGS
dc.subjectECONOMIC CONSEQUENCES
dc.subjectECONOMIC IMPACT
dc.subjectECONOMIC INCENTIVES
dc.subjectEVALUATION CRITERIA
dc.subjectFAMILIES
dc.subjectFEASIBILITY
dc.subjectFINANCIAL FEASIBILITY
dc.subjectGENERIC PRODUCTS
dc.subjectHEALTH CARE
dc.subjectHEALTH INSURANCE
dc.subjectHEALTH PROBLEMS
dc.subjectHEALTH SERVICES
dc.subjectHIV
dc.subjectHIV INFECTION
dc.subjectHIV POSITIVE
dc.subjectHIV PREVALENCE
dc.subjectHIV TEST
dc.subjectHIV TESTING
dc.subjectHIV TRANSMISSION
dc.subjectHIV-POSITIVE PEOPLE
dc.subjectHUMAN DEVELOPMENT
dc.subjectILLNESS
dc.subjectIMMUNE SYSTEM
dc.subjectIMPORTS
dc.subjectINCIDENCE OF HIV
dc.subjectINCOME
dc.subjectINCOME LEVELS
dc.subjectINFECTION RATES
dc.subjectISOLATION
dc.subjectLEGISLATION
dc.subjectMALARIA
dc.subjectMALNUTRITION
dc.subjectMEDICAL SUPPLIES
dc.subjectMEDICINE
dc.subjectMEDICINES
dc.subjectMORBIDITY
dc.subjectMORTALITY
dc.subjectMOTHER-TO-CHILD
dc.subjectOPPORTUNISTIC INFECTIONS
dc.subjectORPHANS
dc.subjectPALLIATIVE CARE
dc.subjectPANDEMIC
dc.subjectPATENTS
dc.subjectPATIENTS
dc.subjectPEOPLE WITH AIDS
dc.subjectPEOPLE WITH HIV
dc.subjectPHARMACEUTICAL MANUFACTURERS
dc.subjectPHARMACEUTICAL POLICY
dc.subjectPHARMACEUTICAL PROCUREMENT
dc.subjectPHARMACEUTICAL PRODUCTS
dc.subjectPHARMACEUTICAL SUPPLY
dc.subjectPOOLED PROCUREMENT
dc.subjectPREVENTION OF MOTHER-TO-CHILD TRANSMISSION
dc.subjectPROCUREMENT
dc.subjectPRODUCERS
dc.subjectPRODUCTION COSTS
dc.subjectPROJECT IMPLEMENTATION
dc.subjectPROPERTY RIGHTS
dc.subjectPSYCHOSOCIAL SUPPORT
dc.subjectPUBLIC HEALTH
dc.subjectPUBLIC SECTOR
dc.subjectPURCHASING
dc.subjectQUALITY ASSURANCE
dc.subjectQUALITY CONTROL
dc.subjectQUALITY OF LIFE
dc.subjectQUALITY STANDARDS
dc.subjectRESOURCE ALLOCATION
dc.subjectSAFETY
dc.subjectSERVICE DELIVERY
dc.subjectSOCIAL MARKETING
dc.subjectTREATMENT POLICIES
dc.subjectTUBERCULOSIS
dc.subjectUNAIDS
dc.subjectVIRAL LOAD
dc.subjectWASTE
dc.subjectWORLD HEALTH ORGANIZATION
dc.titleBattling HIV/AIDS : A Decision Maker's Guide to the Procurement of Medicines and Related Suppliesen
dc.title.alternativeLucha contra le VIH/SIDA : guia para los responsables de la toma de decisiones sobre las medicinas y otros suministros Combattre le VIH/SIDA : Guide a l'intention des responsables de la passation des marches de medicaments et produits connexesen
dspace.entity.typePublication
okr.doctypePublications & Research::Publication
okr.doctypePublications & Research::Publication
okr.docurlhttp://documents.worldbank.org/curated/en/2004/01/4987913/battling-hivaids-decision-makers-guide-procurement-medicines-related-supplies
okr.globalpracticeHealth, Nutrition, and Population
okr.guid694101468161668216
okr.guid342831468332074516
okr.guid573861468762607386
okr.identifier.doi10.1596/0-8213-5848-0
okr.identifier.externaldocumentum000090341_20040730152040
okr.identifier.internaldocumentum4987913
okr.identifier.report29707
okr.language.supporteden
okr.pdfurlhttp://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2004/07/30/000090341_20040730152040/Rendered/PDF/297070PAPER0Battling0HIV0Aids.pdfen
okr.topicHealth, Nutrition and Population::HIV AIDS
okr.topicHealth Monitoring and Evaluation
okr.topicPrivate Sector Development::HIV AIDS and Business
okr.topicPharmaceuticals and Pharmacoeconomics
okr.topicEnvironmental Economics and Policies
okr.volume1 of 1
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
297070PAPER0Battling0HIV0Aids.pdf
Size:
3.62 MB
Format:
Adobe Portable Document Format
Download
No Thumbnail Available
Name:
297070PAPER0Battling0HIV0Aids.txt
Size:
392.46 KB
Format:
Plain Text
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description:
Download
Collections
Stand alone books